对抗凝血药物的共同决策减少了焦虑,并改善了心房动患者的坚持
Hsiao-Hui Chiu1,2, Shih-Lin Chang3,4,5, Hao-Min Cheng6
1Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
BMC medical informatics and decision making
|August 23, 2023
概括
共享决策 (SDM) 显著降低了心房动 (AF) 患者的焦虑,并改善了考虑口服抗凝剂 (OAC) 患者的治疗坚持. 这种方法提高了对中风预防策略的理解和接受.
科学领域:
- 心脏病学 心脏病学
- 患者的决策制定 患者的决策
- 公共卫生 公共卫生
背景情况:
- 口服抗凝剂 (OAC) 对于预防心房动 (AF) 中的中风至关重要.
- 患者对OAC副作用的焦虑可能会阻碍治疗决策.
- 共享决策 (SDM) 可以减轻焦虑并改善坚持.
研究的目的:
- 评估SDM对AF患者焦虑水平的影响.
- 评估SDM是否改善了对中风预防措施的遵守,特别是OAC.
主要方法:
- 在52名AF患者中采用了前测试后测试设计.
- 一个患者决策辅助 (PDA) 工具促进了SDM和问卷填写.
- 患者对SDM和焦虑评分的识别使用5分级来衡量.
主要成果:
- 患者在"非常" (4.17/5) 以上的水平上识别了SDM.
- 患者的焦虑评分在SDM (3.56~2.92,p<0.001) 后显著下降.
- 采取OAC的决定增加了 (76.9%至88.5%),而"不清楚"的反应减少了 (p = 0.006).
结论:
- SDM有效地提高了对OAC治疗优缺点的理解.
- SDM显然可以减少患者对AF治疗选择的焦虑.
- SDM增加了患者接受推的中风预防治疗的意愿.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25


